6-year-old in China dies after experimental treatment, investigation finds, raising questions about the country's gene therapy regulations
livescience - A young girl in China died after being given an experimental gene therapy intended to treat a neurodevelopmental syndrome, an investigation by Science and Retraction Watch revealed.
AI Summary: An investigation found a six‑year‑old patient died following an experimental gene‑editing treatment in China, and that the fatality was not promptly disclosed. The case has reignited scrutiny of the country’s gene therapy oversight and raised urgent questions about trial transparency, consent and regulatory enforcement.
Related Stories
Single‑infusion gene editing dramatically lowers LDL cholesterol in early trial / 3 months
Ultragenyx gene therapy becomes first FDA‑approved treatment for ultra‑rare disease / 17 days
AI model identifies improved cancer outcomes globally / 7 months
Scientists precisely edit human embryo genes, reigniting safety debate / 3 months
Gene therapy restores hearing in about 90% of trial participants / 4 months
FDA scrutinizes peptide injections popularized by RFK Jr. and influencers / 6 wks
Personalized genetic therapy yields improvements in children with rare epilepsy / 6 wks
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Vitamin D, Mergers and Acquisitions, Medical Devices, Supplements and look for the RSS link.
StackHealth Time Machine